Superoxide Dismutase Inhibitors against Malaria, Leishmaniasis, and Chagas Disease: Systematic Review.
Curr Drug Targets
; 24(2): 201-210, 2023.
Article
in English
| MEDLINE | ID: covidwho-2291450
ABSTRACT
INTRODUCTION:
Diseases caused by protozoa are one of the leading causes of death worldwide, especially in tropical regions such as Brazil. Chagas disease, leishmaniasis, and malaria are responsible for around 234 million cases and more than 400,000 deaths worldwide. Despite this scenario, drugs for these diseases have several limitations, which justifies the search for new treatments. Iron superoxide dismutase is a promising target for the drug design to treat patients with these diseases. It is a validated target and protects against oxidative stress.AIM:
Thus, this systematic review aimed to synthesize evidence on the importance of superoxide dismutase in the drug design to treat patients with this protozoosis.METHODS:
A search was performed for in vitro and in vivo studies, without publication and language restrictions, in MEDLINE (PubMed), LILACS (BVS), Science Direct, and EMBASE (Elsevier). Studies that pointed to the relationship between the reduction or increase in superoxide dismutase activity and the diseases were included. 23 studies were selected for the qualitative synthesis.RESULTS:
The results showed that the inhibition or reduction of the enzyme activity decreases the degree of infection and reinfection and improves the results in treating these diseases. In contrast, the increase in activity caused a high degree of survival and resistance of the parasites.CONCLUSION:
However, the overall quality of evidence is low and more studies with methodological rigor are provided.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Leishmaniasis
/
Chagas Disease
/
Malaria
Type of study:
Prognostic study
/
Qualitative research
/
Reviews
/
Systematic review/Meta Analysis
Limits:
Humans
Language:
English
Journal:
Curr Drug Targets
Journal subject:
Drug Therapy
Year:
2023
Document Type:
Article
Affiliation country:
1389450124666221209105822
Similar
MEDLINE
...
LILACS
LIS